3PC-023 临床试验管理部门的新活动：员工面临哪些新风险？

{"title":"3PC-023 临床试验管理部门的新活动：员工面临哪些新风险？","authors":"A. Boutin, B. Petitjean, F. Foursac, M. Antignac, F. Chabonnier Beaupel, C. Metz","doi":"10.1136/ejhpharm-2024-eahp.80","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":335223,"journal":{"name":"Section 3: Production and Compounding","volume":"320 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"3PC-023 New activities within a clinical trial management unit: what new risks for the staff?\",\"authors\":\"A. Boutin, B. Petitjean, F. Foursac, M. Antignac, F. Chabonnier Beaupel, C. Metz\",\"doi\":\"10.1136/ejhpharm-2024-eahp.80\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":335223,\"journal\":{\"name\":\"Section 3: Production and Compounding\",\"volume\":\"320 \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 3: Production and Compounding\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-eahp.80\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 3: Production and Compounding","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.80","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}